Form D · Other Technology
Arise Health, Inc.
New York, NY · CIK 0002009243
Offering snapshot reported Jan 24, 2024 · SEC filing
- Reported sold
- $6.48M Offering amount: $7.13M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 12, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 24, 2024 | Initial | $6,479,998 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-503288
Total amount sold includes $4,130,000 in SAFE conversions.
Source: Form D, filed Jan 24, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nisha Dua | Director |
| Joan Zhang | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
228 Park Ave., S Pmb 42111
New York, NY, 10003
New York, NY, 10003